Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
2.340
+0.090 (4.00%)
At close: May 30, 2025, 4:00 PM
2.320
-0.020 (-0.85%)
After-hours: May 30, 2025, 6:49 PM EDT
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $65.23 million as of May 30, 2025. Its market cap has increased by 12.25% in one year.
Market Cap
65.23M
Enterprise Value
50.37M
1-Year Change
12.25%
Ranking
Category
Stock Price
$2.34
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has decreased from $65.74M to $65.23M, a decrease of -0.78%. That is a compound annual growth rate of -0.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 65.23M | 7.79% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.23B |
| Johnson & Johnson | 373.45B |
| AbbVie | 328.75B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.41B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |